Location: Home
  • search
  • go
  • Relate News
  • 8/12/2018Sanpower Sell Dendreon to Affiliate Nanjing Cenbest for $820M
  • 8/10/2018Recent Executive Moves
  • 8/9/2018Review of Chinese Pharma Deals, R&D and Regulatory Developments in...
  • 8/9/2018SMIA Official: BMI Negotiation for 18 Anticancers To Be Concluded by S...
  • 8/9/2018China Approves Amgen's Anti-cholesterol Drug Repatha
  • 8/9/2018Harbour BioMed and Glenmark Pharma Sign Agreement for Greater China to...
  • 8/8/2018CDE Solicits Comments on List of Urgently-needed New Drugs Marketed Ov...
  • 8/8/2018IQVIA: Overview of the Chinese Pharmaceutical Market in 2017
  • 8/8/2018Novartis Voluntarily Withdraws Zemeta for Injection in China, Followin...
  • 8/7/2018MorphoSys and I-Mab Announce China IND Submission of mAb for MM
  • 8/7/2018State Council Issues New Guideline to Enhance Medical Sector Regulatio...
  • 8/7/2018Can-Fite and with CMS Medical Sign License Agreement for Piclidenoson ...
  • 8/6/2018Harbour BioMed and Glenmark Pharma Sign Anticancer License Agreement f...
  • 8/3/2018Recent Executive Moves
  • 8/3/2018China Isn't Yet Ready to Conduct Clinical Trials for The Pharma Indust...
  • 8/3/2018Nobel Laureate to Launch Biomedicine Laboratory in Shenzhen
  • 8/3/2018Acticor Licenses Stroke Medicine to CMS in China and Select Asian Mark...
  • 8/2/2018Clover Biopharma Initiates Phase I Study of Etanercept Biosimilar in C...
  • 8/1/2018SMIA to Hold Meeting Seeking Feedbacks on the Upcoming National Level ...
  • 7/31/2018Korea's SillaJen and Medytox Prepare for China Business Takeoffs
  • 7/27/2018CNDA Announces Adjustment of Drug Clinical Trial Evaluation and Approv...
  • 7/27/2018Recent Executive Moves
  • 7/27/2018Neovii Licenses Transplant Drug Grafalon In China And Japan
  • 7/27/2018Bio-Thera Initiates Phase I Trial for Biosimilar of Actemra (Tocilizum...
  • 7/27/2018I-Mab and ABL Bio Announce Partnership on Novel Bispecific Antibodies
  • 7/26/2018CBT Pharma Initiates Phase 1b Trial for Anti-PD-1 Antibody Drug
  • 7/26/2018First National Drug Supply Consortium Formed under Government Guidance
  • 7/26/2018SMIA: Urban and Rural Resident BMI Programs To Be Uniformed in 2019
  • 7/26/2018MSD Announces Chinese Approval of Its Blockbuster Anticancer Drug Keyt...
  • 7/26/2018China Presses Pharma Cos to Lower Anticancer Drug Prices As Prevalence...
  • Page:158/357 Total number of articles:10705: [First][<<] [156] [157] [158] [159] [160] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group